Home > Name List By e > Everolimus

CAS No 159351-69-6 , Everolimus

  • Name: Everolimus
  • Synonyms: SDZRAD;Everolimus; RAD-001; 42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin; Certica; Certican; Rapamycin, 42-O-(2-hydroxyethyl)-; CERTICAN(R);42-O-(2-Hydroxyethyl)-rapamycin;
  • CAS Registry Number:
  • Melting Point: NA
  • Density: 1.18 g/cm3
  • Refractive index: 1.548
  • Water Solubility: Soluble in DMSO and ethanol, up to about 25 mg/mL
  • Safety Statements: R48/25,
  • Hazard Symbols: T:;
  • Molecular Weight: 958.22
  • InChI: InChI=1/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
  • Risk Statements: S45,
  • Molecular Formula: C53H83NO14
  • Molecular Structure:CAS No:159351-69-6 Everolimus

Related products

Search by region :

Select to

159351-69-6 Everolimus

  • China Melone Pharmaceutical Co., Ltd. [Manufacturer]
  • Tel: +86-41182593631/ +86-41182702105
  • Fax: +86-41182593613
  • Address: Room 2209,No.232, Jinma Road,
    Development Zone,
    Dalian, China 116600 null,nullChina
Contact Supplier

159351-69-6 EVEROLIMUS

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

159351-69-6 Everolimus

Contact Supplier

159351-69-6 Everolimus

  • China Nanjing Samwon International Limited [Importer/Exporter]
  • Tel: +86-(25)-84873444
  • Fax: +86-(25)-84507436
  • Address: 1108, BLDG B, New Century Plaza, No 1, South Taiping Rd., Nanjing, Jiangsu 210002, Nanjing,JiangsuChina
Contact Supplier

159351-69-6 Everolimus

  • China Taizhou Crene Chempharm Co., Ltd. null
  • Tel: +86-(576)-88813233
  • Fax: +86-(576)-88670057
  • Address: Weiwu Load Economic Developed Zone, Taizhou, Zhejiang 318000, null,nullChina
Contact Supplier

159351-69-6 EVEROLINUS

  • China Apichem Chemical Technology Co., Ltd [Manufacturer]
  • Tel: 86-137-6120-5405/ 86-21-3762-3285
  • Address: Apichem Chemical Technology Co., Ltd
    room 102, No.22,lane 288,
    Qianshao Road,
    Pudong, shanghai 201201 China null,nullChina
Contact Supplier

159351-69-6 Everolimus

  • China Shanghai Yishi Chemical Technology Co., Ltd [Manufacturers]
  • Tel: 021-61127689 13816561402
  • Fax: 021-61177038
  • Address: Shanghai Torch innovation Park of Fine Chemical Industry, No. 688 Qiushi Road, Jinshan District, Shanghai China Shanghai,ShanghaiChina
Contact Supplier

159351-69-6 Everolimus

  • China Hangzhou Yanshan Chemical Co.,Ltd [Manufacturer]
  • Tel: 86-571-86696867/ 86-571-86897279
  • Fax: 86-571-28050260
  • Address: Hangzhou Yanshan Chemical Co.,Ltd
    2/F,Block 8,No.198,Jiaogong Road,
    Hangzhou,China null,nullChina
Contact Supplier

159351-69-6 Everolimus

  • China Yongyi Biotechnology Co,.Ltd [Importer/Exporter]
  • Tel: +86-21-60904639
  • Fax: +86-21-60904609
  • Address: Suite 3005, City Gateway, No.398 North CaoXi Road, XuHui District, Shanghai 200030, China. null,nullChina
Contact Supplier

159351-69-6 Everolimus

  • Everolimus, 98,0%
  • United States LC Laboratories [Manufacturer]
  • Tel: 781-937-0777
  • Fax: 781-938-5420
  • Address: LC Laboratories
    165 New Boston Street
    Woburn, MA 01801 USA null,nullUnited States
Contact Supplier

Select to

References of Everolimus
Title: Everolimus
CAS Registry Number: 159351-69-6
CAS Name: 42-O-(2-Hydroxyethyl)rapamycin
Synonyms: 40-O-(2-hydroxyethyl)rapamycin
Manufacturers' Codes: RAD-001; SDZ RAD
Trademarks: Certican (Novartis)
Molecular Formula: C53H83NO14
Molecular Weight: 958.22
Percent Composition: C 66.43%, H 8.73%, N 1.46%, O 23.38%
Literature References: Macrolide immunosuppressant; derivative of rapamycin, q.v. Inhibits cytokine-mediated lymphocyte proliferation. Prepn: S. Cottens, R. Sedrani, WO 9409010; eidem, US 5665772 (1994, 1997 both to Sandoz). Pharmacology: W. Schuler et al., Transplantation 64, 36 (1997). Whole blood determn by LC/MS: N. Brignol et al., Rapid Commun. Mass Spectrom. 15, 898 (2001); by HPLC: S. Baldelli et al., J. Chromatogr. B 816, 99 (2005). Clinical pharmacokinetics in combination with cyclosporine: J. M. Kovarik et al., Clin. Pharmacol. Ther. 69, 48 (2001). Clinical study in prevention of cardiac-allograft vasculopathy: H. J. Eisen et al., N. Engl. J. Med. 349, 847 (2003). Review: F. J. Dumont et al., Curr. Opin. Invest. Drugs 2, 1220-1234 (2001); B. Nashan, Ther. Drug Monit. 24, 53-58 (2002).
Therap-Cat: Immunosuppressant.
Keywords: Immunosuppressant.